Animal study · mice

Ac-SDKP taken by mouth eased kidney scarring in diabetic mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This paper adds mouse evidence that oral Ac-SDKP, alone or with imidapril, reduced kidney scarring in diabetic models. It is an animal finding, not proof of benefit in people.

Kind
Animal study
Studied in
Mice
Published
2016
Journal
Biomed Res Int

What they tested

The team tested whether Ac-SDKP given by mouth, alone or with the ACE inhibitor imidapril, could treat kidney scarring (fibrosis) in diabetic mice.

How the study was done

A mouse study using models of diabetic kidney disease: CD-1 mice made type 1 diabetic with streptozotocin, and db/db mice with type 2 diabetes. Treated groups got imidapril, oral Ac-SDKP, or both together.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Ac-SDKP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In both diabetic mouse models, every treatment raised Ac-SDKP levels in urine, and the combination group had significantly higher levels than the other groups. Oral Ac-SDKP, alone or with imidapril, lessened glomerulosclerosis (scarring of the kidney's filtering units) and tubulointerstitial fibrosis (scarring in the tissue around the kidney tubules). Plasma cystatin C, a blood marker of kidney function, was raised in the diabetic mice and was restored by every treatment. Kidney levels of miR-29 and let-7, small RNAs the team describes as anti-scarring, were low in the diabetic mice and came back to normal or higher, especially with the combination.

What it doesn’t show

This was done in mice, so it is not a result in people. The study did not test oral Ac-SDKP in humans with diabetic kidney disease.

The paper

Nitta et al. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. Biomed Res Int. 2016.

The compound

More studies on Ac-SDKP

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Ac-SDKP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo